| Randomized trial of thymectomy in myasthenia gravis GI Wolfe, HJ Kaminski, IB Aban, G Minisman, HC Kuo, A Marx, P Ströbel, ... New England Journal of Medicine 375 (6), 511-522, 2016 | 889 | 2016 |
| MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT DW Paty, JJF Oger, LF Kastrukoff, SA Hashimoto, JP Hooge, AA Eisen, ... Neurology 38 (2), 180-180, 1988 | 874 | 1988 |
| A full genome search in multiple sclerosis GC Ebers, K Kukay, DE Bulman, AD Sadovnick, G Rice, C Anderson, ... Nature genetics 13 (4), 472-476, 1996 | 852 | 1996 |
| Depression and multiple sclerosis AD Sadovnick, RA Remick, J Allen, E Swartz, IML Yee, K Eisen, ... Neurology 46 (3), 628-632, 1996 | 724 | 1996 |
| Evidence for a two-stage disability progression in multiple sclerosis E Leray, J Yaouanq, E Le Page, M Coustans, D Laplaud, J Oger, G Edan Brain 133 (7), 1900-1913, 2010 | 718 | 2010 |
| Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled … L Kappos, G Comi, H Panitch, J Oger, J Antel, P Conlon, L Steinman, ... Nature medicine 6 (10), 1176-1182, 2000 | 602 | 2000 |
| Potassium channel antibodies in two patients with reversible limbic encephalitis C Buckley, J Oger, L Clover, E Tüzün, K Carpenter, M Jackson, A Vincent Annals of Neurology: Official Journal of the American Neurological …, 2001 | 561 | 2001 |
| Water content and myelin water fraction in multiple sclerosis: A T2 relaxation study C Laule, IM Vavasour, GRW Moore, J Oger, DKB Li, DW Paty, AL MacKay Journal of neurology 251, 284-293, 2004 | 473 | 2004 |
| Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis A Shirani, Y Zhao, ME Karim, C Evans, E Kingwell, ML Van Der Kop, ... Jama 308 (3), 247-256, 2012 | 340 | 2012 |
| Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients EW Willoughby, E Grochowski, DKB Li, J Oger, LF Kastrukoff, DW Paty Annals of neurology 25 (1), 43-49, 1989 | 321 | 1989 |
| Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial DS Goodin, AT Reder, GC Ebers, G Cutter, M Kremenchutzky, J Oger, ... Neurology 78 (17), 1315-1322, 2012 | 310 | 2012 |
| Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM) CMD Castro-Costa, AQC Araújo, MM Barreto, OM Takayanagui, ... AIDS Research & Human Retroviruses 22 (10), 931-935, 2006 | 310 | 2006 |
| Interrupted therapy: stopping and switching of the β-interferons prescribed for MS HL Tremlett, J Oger Neurology 61 (4), 551-554, 2003 | 275 | 2003 |
| Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis CH Polman, A Bertolotto, F Deisenhammer, G Giovannoni, HP Hartung, ... The Lancet Neurology 9 (7), 740-750, 2010 | 271 | 2010 |
| Bilirubin possesses powerful immunomodulatory activity and suppresses experimental autoimmune encephalomyelitis Y Liu, P Li, J Lu, W Xiong, J Oger, W Tetzlaff, M Cynader The Journal of Immunology 181 (3), 1887-1897, 2008 | 259 | 2008 |
| Multiple sclerosis: a serial study using MRI in relapsing patients C Isaac, DK B. Li, M Genton, C Jardine, E Grochowski, M Palmer, ... Neurology 38 (10), 1511-1511, 1988 | 254 | 1988 |
| Neutralizing antibodies to interferon beta: Assessment of their clinical and radiographic impact: An evidence report:[RETIRED] Report of the Therapeutics and Technology … DS Goodin, EM Frohman, B Hurwitz, PW O’Connor, JJ Oger, AT Reder, ... Neurology 68 (13), 977-984, 2007 | 231 | 2007 |
| A pathology-MRI study of the short-T2 component in formalin-fixed multiple sclerosis brain GRW Moore, E Leung, AL MacKay, IM Vavasour, KP Whittall, KS Cover, ... Neurology 55 (10), 1506-1510, 2000 | 216 | 2000 |
| Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: A prospective 2‐year follow‐up with comparison of clinical evaluation, evoked potentials … KH Lee, SA Hashimoto, JP Hooge, LF Kastrukoff, JJF Oger, DKB Li, ... Neurology 41 (5), 657-660, 1991 | 205 | 1991 |
| Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada E Kingwell, M Van der Kop, Y Zhao, A Shirani, F Zhu, J Oger, H Tremlett Journal of Neurology, Neurosurgery & Psychiatry 83 (1), 61-66, 2012 | 204 | 2012 |
